Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
Altamira Therapeutics GAAP EPS of -$0.55
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules
Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine
Earnings Call Summary | Altamira Therapeutics Ltd(CYTOF.US) Q4 2024 Earnings Conference
Altamira Therapeutics Ltd | 20-F: FY2024 Annual Report